Literature DB >> 15020184

Accuracy of self-reported smoking status among participants in a chemoprevention trial.

María Elena Martínez1, Mary Reid, Ruiyun Jiang, Janine Einspahr, David S Alberts.   

Abstract

BACKGROUND: Exposure to tobacco products is readily assessed through self- or interview-administered questionnaires. Degree of misreporting among participants in chemoprevention trials is unknown. We assessed the level of discrepancy between self-reported smoking exposure and plasma cotinine among participants in a chemoprevention trial.
METHODS: Analyses were conducted among 824 men and women who participated in a dietary trial of adenoma recurrence. Smoking exposure was ascertained through self-administered questionnaires at three time-points. Plasma cotinine was measured by gas chromatography among 283 never, 446 former and 95 current self-reported smokers. Sensitivity and specificity were assessed using various plasma cotinine cut-points.
RESULTS: Degree of misclassification for self-reported current smokers was minor (0-3%), regardless of cotinine cut-point used. Using a cut-point of 20 ng/ml, which takes into account exposure to environmental tobacco smoke among nonsmokers, sensitivity and specificity were 98.9% and 80.2%, respectively.
CONCLUSIONS: These data indicate that degree of misreport for current smokers is extremely low; however, approximately 20% of self-reported never smokers misreport their exposure, suggesting that validation of self-report is needed for these individuals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15020184     DOI: 10.1016/j.ypmed.2003.12.006

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  21 in total

1.  Who conceals their smoking status from their health care provider?

Authors:  Jennifer Stuber; Sandro Galea
Journal:  Nicotine Tob Res       Date:  2009-02-20       Impact factor: 4.244

Review 2.  Deception in clinical trials and its impact on recruitment and adherence of study participants.

Authors:  Chuen Peng Lee; Tyson Holmes; Eric Neri; Clete A Kushida
Journal:  Contemp Clin Trials       Date:  2018-08-21       Impact factor: 2.226

3.  Complex segregation analysis reveals a multigene model for lung cancer.

Authors:  Hongyan Xu; Margaret R Spitz; Christopher I Amos; Sanjay Shete
Journal:  Hum Genet       Date:  2004-11-16       Impact factor: 4.132

Review 4.  Biochemical Verification of Tobacco Use and Abstinence: 2019 Update.

Authors:  Neal L Benowitz; John T Bernert; Jonathan Foulds; Stephen S Hecht; Peyton Jacob; Martin J Jarvis; Anne Joseph; Cheryl Oncken; Megan E Piper
Journal:  Nicotine Tob Res       Date:  2020-06-12       Impact factor: 4.244

5.  Estimates of cutoffs with specificities and sensitivities for urine cotinine and hydroxycotinine for US adults aged ≥ 20 years to classify smokers and nonsmokers.

Authors:  Ram Baboo Jain
Journal:  Environ Sci Pollut Res Int       Date:  2020-01-17       Impact factor: 4.223

Review 6.  Tobacco use and cessation for cancer survivors: an overview for clinicians.

Authors:  Maher Karam-Hage; Paul M Cinciripini; Ellen R Gritz
Journal:  CA Cancer J Clin       Date:  2014-05-09       Impact factor: 508.702

7.  Does timing and sequencing of transitions to adulthood make a difference? Stress, smoking, and physical activity among young Australian women.

Authors:  Sandra Bell; Christina Lee
Journal:  Int J Behav Med       Date:  2006

8.  Smoking status and pain level among head and neck cancer patients.

Authors:  Henrietta L Logan; Roger B Fillingim; Linda M Bartoshuk; Pamela Sandow; Scott L Tomar; John W Werning; William M Mendenhall
Journal:  J Pain       Date:  2009-12-16       Impact factor: 5.820

9.  Impact of smoking on patients with stage III colon cancer: results from Cancer and Leukemia Group B 89803.

Authors:  Nadine Jackson McCleary; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Paul Schaefer; Renaud Whittom; Alexander Hantel; Al Benson; Richard Goldberg; Jeffrey A Meyerhardt
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

10.  Integrating tobacco treatment into cancer care: Study protocol for a randomized controlled comparative effectiveness trial.

Authors:  Elyse R Park; Jamie S Ostroff; Giselle K Perez; Kelly A Hyland; Nancy A Rigotti; Sarah Borderud; Susan Regan; Alona Muzikansky; Emily R Friedman; Douglas E Levy; Susan Holland; Justin Eusebio; Lisa Peterson; Julia Rabin; Jacob Miller-Sobel; Irina Gonzalez; Laura Malloy; Maureen O'Brien; Suhana de León-Sanchez; C Will Whitlock
Journal:  Contemp Clin Trials       Date:  2016-07-19       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.